Neurochecks for Brain Injury
Trial Summary
What is the purpose of this trial?
The proposed research plan seeks to understand the impact of sleep disruption in the Neurological Intensive Care Unit (ICU) on older patients with acute brain injury (ABI). In current practice, the neurocritical care community performs frequent serial neurological examinations ("neurochecks") in an effort to monitor patients for neurological deterioration following brain injury. Many neurocritical patients are older and/or cognitively fragile, and delirium is common. Although ICU delirium is multifaceted, frequent neurochecks may represent a modifiable risk factor if the investigators can better understand the risks and benefits of various neurocheck frequencies. This project will randomize patients with acute spontaneous intracerebral hemorrhage (ICH) to either hourly (Q1) or every-other-hour (Q2) neurochecks and evaluate the impact of neurocheck frequency on delirium. Second, longer-term cognitive outcomes will be investigated in patients with ICH randomized to Q1 versus Q2 neurochecks with the goal of identifying whether hourly neurochecks increase the risk for dementia.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Frequency of neurochecks for brain injury?
The research indicates that while neurochecks are commonly used to detect changes in brain function after an injury, there is limited scientific study on their effectiveness, especially in conditions like stroke. There is a need for more rigorous evaluation to understand their benefits and risks, including potential sleep disruption.12345
Is it safe to participate in clinical trials involving neurochecks for brain injury?
How is the treatment of neurochecks for brain injury different from other treatments?
Neurochecks involve frequent neurological exams to monitor brain function, which is unique because it focuses on early detection of changes rather than direct intervention. Unlike other treatments that may involve medication or surgery, neurochecks are non-invasive and rely on regular assessments to prevent further injury, though they may disrupt sleep and contribute to additional issues like delirium.1241011
Eligibility Criteria
This trial is for older patients in the ICU with acute brain injuries from conditions like bleeding or stroke. It's looking at how often they should be checked for changes in their condition (neurochecks). Patients must not have other factors that could cause delirium, and they need to be able to participate in follow-up tests.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients are randomized to hourly or every-other-hour neurochecks during their ICU stay to monitor the impact on delirium and cognitive outcomes.
Follow-up
Participants are monitored for long-term cognitive outcomes and other psychological measures at 6 months post-discharge.
Treatment Details
Interventions
- Frequency of neurochecks
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor